# LTR 146: Ganesh Sabat on Scaling MedTech Through Quality

Page: https://stenobird.com/podcast/let-s-talk-risk-podcast-6693844/ltr-146-ganesh-sabat-on-scaling-medtech-through-quality
Text version: https://stenobird.com/podcast/let-s-talk-risk-podcast-6693844/ltr-146-ganesh-sabat-on-scaling-medtech-through-quality.md
Podcast: [Let's Talk Risk! Podcast](https://stenobird.com/podcast/let-s-talk-risk-podcast-6693844)
Published: 2026-03-06T13:00:00+00:00
Episode link: https://naveenagarwalphd.substack.com/p/ltr-146-ganesh-sabat-on-scaling-medtech-through-quality
Audio file: https://api.substack.com/feed/podcast/188915116/0fb9590a5e625afde2889e242f3d7567.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/let-s-talk-risk-podcast-6693844/episodes/ltr-146-ganesh-sabat-on-scaling-medtech-through-quality
Duration seconds: 1535

## Resource

Summary “A company can become world class the day the quality team decides.” In this Let’s Talk Risk! conversation , host Naveen Agarwal engages with Ganesh Sabat, former former CEO of Sahajanand Medical Technologies (SMT) and now Founder & Managing Partner of MedArtha Capital about a simple but hard truth: global scale in MedTech is earned through quality execution, not marketing narratives. Ganesh walks through SMT’s transformation from an innovative startup into a globally recognized cardiovascular device company, then zooms out to India’s broader MedTech ambition. We unpack what’s missing (talent depth, shared learning, true design ownership), what’s emerging (incubation + device parks + incentives), and why quality leaders are the real “make-or-break” force behind India’s credibility on the world stage. Listen to the full 30-minute podcast or jump to a section of interest listed below. Chapters 00:00 Welcome and Introduction 02:09 SMT story: from “innovative startup” to global scale 04:54 The turning point: why Ganesh bet on quality as the growth lever 06:13 What investors demanded: proof, discipline, and scalable systems 08:39 India ecosystem reality: pharma-quality mindset vs device-grade rigor 11:22 “Quality as a system”: building defect prevention into process + design 15:21 Building the ecosystem: why shared learning + capability depth matter 18:58 Challenges and opportunities for MedTech startup 21:02 Achieving global success not through low-cost but high quality 24:25 Closing remarks If you enjoyed this podcast, consider subscribing to the Let’s Talk Risk! newsletter . Suggested links: LTR: What QA/RA Professionals Need to Know About MedTech in India . LTR: Navigating the Regulatory Landscape for SaMD in India . LTR: Atty Chakraborty on India’s Rising MedTe…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/let-s-talk-risk-podcast-6693844/episodes/ltr-146-ganesh-sabat-on-scaling-medtech-through-quality/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/let-s-talk-risk-podcast-6693844/ltr-146-ganesh-sabat-on-scaling-medtech-through-quality.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.